Tate & Lyle (TATE) AI Stock Analysis

• Market Cap: £1.67B
• Dividend Yield: 5.27%
• Average Volume (3M): 2.61M
• Price to Earnings (P/E): 49.1
• Beta (1Y): 0.84
• Revenue Growth: 26.84%
• EPS Growth: -81.73%
• Country: UK
• Employees: 3,318
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.21
• Shares Outstanding: 445,446,780
• 10 Day Avg. Volume: 2,809,626
• 30 Day Avg. Volume: 2,611,880
• PEG Ratio: -0.61
• Price to Book (P/B): 4.01
• Price to Sales (P/S): 3.67
• P/FCF Ratio: 148.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £473.07
• Price Target Upside: 25.22% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 9
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: 401.00p ▲(6.14% Upside)

Tate & Lyle's overall stock score reflects stable financial performance and positive corporate events, such as insider share purchases. However, technical indicators and valuation suggest caution, with high P/E ratios and neutral momentum. Earnings call insights highlight current market challenges, balancing the positive aspects.

Positive Factors

CP Kelco Merger Success

The successful integration and cross-selling opportunities from the CP Kelco merger enhance Tate & Lyle's market reach and growth potential, indicating a strategic advantage that can drive long-term revenue growth.

Strong Sucralose Demand

Consistent strong demand for sucralose supports stable revenue streams and highlights Tate & Lyle's competitive position in the sweeteners market, contributing to sustained business performance.

Productivity Program on Track

Effective execution of the productivity program ensures operational efficiency, cost savings, and margin improvement, strengthening Tate & Lyle's financial health and competitiveness.

Negative Factors

Revenue and EBITDA Decline

Anticipated declines in revenue and EBITDA reflect challenging market conditions, which may pressure financial performance and limit growth opportunities in the near to medium term.

Challenging Market Conditions

Difficult market conditions, especially in key regions like North America, can impede sales growth and profitability, posing risks to Tate & Lyle's business stability and expansion efforts.

Impact of Tariffs

Tariff impacts can disrupt supply chains and increase costs, potentially eroding margins and affecting Tate & Lyle's competitive positioning in affected markets.

Tate & Lyle Business Overview & Revenue Model

Company Description

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Tate & Lyle generates revenue primarily through the sale of its specialty ingredients and solutions to the food and beverage industry. Key revenue streams include the production and sale of sweeteners, such as high-fructose corn syrup and sucralose, as well as texturants that improve food texture and stability. The company also benefits from long-term contracts with major food manufacturers, ensuring a consistent revenue flow. Additionally, Tate & Lyle engages in partnerships and collaborations with other companies to innovate and expand its product offerings, contributing to its earnings. Global demand for healthier and more sustainable food options further drives the company's growth, as it aligns its product development with market trends and consumer preferences.

Tate & Lyle Financial Statement Overview

Summary

Tate & Lyle demonstrates stable financial performance with consistent revenue growth and solid profitability margins. The balance sheet shows prudent leverage management, though there are areas for improvement in cash flow consistency and return on equity.

Income Statement

Tate & Lyle has shown a consistent revenue growth with a slight dip in the latest year. The gross profit margin and net profit margin are healthy, although the net profit margin has seen some volatility. EBIT and EBITDA margins indicate stable operational efficiency.

Balance Sheet

The company maintains a moderate debt-to-equity ratio, indicating balanced leverage. The return on equity has been reasonable but slightly declined, suggesting room for improvement in utilizing shareholder funds. The equity ratio is strong, reflecting a solid asset base relative to liabilities.

Cash Flow

Operating cash flow is positive, yet shows fluctuations, affecting free cash flow growth. The company has a stable operating cash flow to net income ratio, demonstrating its ability to convert earnings into cash efficiently.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.99B	1.74B	1.65B	1.75B	1.38B	1.21B
Gross Profit	-69.00M	706.00M	851.00M	733.00M	514.00M	481.00M
EBITDA	254.00M	254.00M	345.00M	279.00M	168.00M	292.00M
Net Income	34.00M	143.00M	188.00M	190.00M	236.00M	253.00M
Balance Sheet
Total Assets	3.60B	3.73B	2.28B	2.51B	3.25B	2.97B
Cash, Cash Equivalents and Short-Term Investments	325.00M	334.00M	437.00M	475.00M	112.00M	371.00M
Total Debt	1.29B	1.31B	590.00M	713.00M	679.00M	786.00M
Total Liabilities	2.05B	2.14B	1.04B	1.32B	1.63B	1.51B
Stockholders Equity	1.55B	1.59B	1.24B	1.19B	1.62B	1.45B
Cash Flow
Free Cash Flow	71.00M	43.00M	98.00M	-12.00M	-45.00M	217.00M
Operating Cash Flow	188.00M	164.00M	208.00M	66.00M	103.00M	369.00M
Investing Cash Flow	-931.00M	-630.00M	-20.00M	835.00M	-113.00M	-205.00M
Financing Cash Flow	452.00M	367.00M	-215.00M	-598.00M	-247.00M	-29.00M

Tate & Lyle Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 377.80
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:TATE, the sentiment is Neutral. The current price of 377.8 is above the 20-day moving average (MA) of 371.75, above the 50-day MA of 374.50, and below the 200-day MA of 473.59, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 53.04 is Neutral, neither overbought nor oversold. The STOCH value of 67.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:TATE.

Tate & Lyle Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CWK	78 Outperform	£2.68B	18.11	15.07%	2.06%	6.96%	28.47%
PFD	76 Outperform	£1.50B	11.37	9.47%	1.62%	0.50%	20.52%
HFG	71 Outperform	£447.89M	11.44	12.72%	7.01%	8.58%	-15.81%
GNC	70 Outperform	£1.10B	19.11	12.23%	0.79%	7.74%	30.09%
ABF	69 Neutral	£14.97B	14.91	9.22%	2.98%	-3.06%	-26.93%
TATE	65 Neutral	£1.67B	49.13	2.48%	5.27%	26.84%	-81.73%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Tate & Lyle Corporate Events

Tate & Lyle Executives Conduct ADR Sale for Portfolio Rebalancing

Tate & Lyle PLC announced that Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis sold 5,000 American Depositary Receipts (ADRs) at a price of $19.80 each, totaling $99,000. This transaction was conducted for year-end portfolio rebalancing and tax alignment purposes, with plans to repurchase ADRs in early 2026. The sale was disclosed in compliance with the Market Abuse Regulation, indicating transparency in the company’s managerial transactions.

Tate & Lyle CFO Increases Shareholding, Signaling Confidence

Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, acquired 15,000 ordinary shares of the company at a price of £3.898 per share, bringing her total holdings to 85,000 shares. This transaction, conducted on the London Stock Exchange, reflects the confidence of the company’s management in its financial health and future prospects, potentially impacting investor sentiment positively.

Tate & Lyle CFO Appointed to JD Sports Board

Tate & Lyle PLC announced that its Chief Financial Officer, Sarah Kuijlaars, has been appointed as a non-executive director at JD Sports Fashion Plc, effective from November 10, 2025. This appointment will see her joining the Audit and Risk Committee and the Nomination Committee, and she will become the Chair of the Audit and Risk Committee starting June 1, 2026. This move could enhance Tate & Lyle’s strategic positioning by strengthening its leadership team with broader industry insights, potentially benefiting stakeholders through improved governance and risk management practices.

Tate & Lyle Reports Interim Results and Dividend Increase

Tate & Lyle PLC announced its preliminary results for the six months ending 30 September 2025, highlighting an interim dividend of 6.6p per share, up from 6.4p in 2024. The company will host a results presentation led by its CEO and CFO, with a live webcast available for analysts and investors. This announcement reflects Tate & Lyle’s continued commitment to shareholder returns and its strategic growth following the acquisition of CP Kelco, positioning the company as a leader in the food ingredient industry.

Tate & Lyle’s Management Shows Confidence with Share Acquisition

Tate & Lyle PLC announced a transaction involving the acquisition of 16,000 ordinary shares by Steve Foots, a Person Discharging Managerial Responsibilities, and Alison Foots, a person closely associated. This transaction, conducted on the London Stock Exchange at a price of £3.699547 per share, aligns with the company’s compliance with the Market Abuse Regulation and reflects the confidence of its management in the company’s future prospects.

Tate & Lyle Director Increases Stake with ADR Purchase

Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of US$20.16 each. This acquisition increases their total holding to 5,000 ADRs, equivalent to 20,000 ordinary shares, and was conducted on the OTCQX exchange. This transaction reflects the confidence of key stakeholders in the company’s future prospects and complies with the Market Abuse Regulation.

Tate & Lyle CEO Increases Stake with Share Purchase

Tate & Lyle PLC announced a significant transaction involving its CEO, Nick Hampton, who acquired 25,000 ordinary shares at a price of £3.688 each, increasing his total shareholding to 951,816 shares. This transaction, conducted on the London Stock Exchange, highlights a vote of confidence in the company’s future prospects by its leadership, potentially impacting investor perceptions and market positioning.

Tate & Lyle Director Increases Stake with ADR Purchase

Tate & Lyle PLC announced that Glenn Fish, a non-executive director and person discharging managerial responsibilities, acquired 1,000 American Depositary Receipts (ADRs) at a price of US$20.50 each. This transaction, conducted on the OTCQX exchange, increases Mr. Fish’s total interest to 5,049.828 ADRs, representing 20,199.3 shares in the company. The acquisition reflects a strategic move by a key company figure, potentially signaling confidence in the company’s future performance and stability.

Tate & Lyle Reports Progress Amid Market Challenges

Tate & Lyle PLC has issued a pre-close statement ahead of its six-month results announcement, highlighting strong customer engagement and early cross-selling successes following its combination with CP Kelco. Despite a slowdown in market demand impacting short-term financial performance, the company is accelerating efforts to drive top-line growth through enhanced customer segmentation and innovation. The integration with CP Kelco is expected to deliver revenue and cost synergies, positioning Tate & Lyle for improved performance in the future, despite current economic volatility.